Your browser doesn't support javascript.
loading
The Role of BRAF-Targeted Therapy for Advanced Melanoma in the Immunotherapy Era.
Vanella, Vito; Festino, Lucia; Trojaniello, Claudia; Vitale, Maria Grazia; Sorrentino, Antonio; Paone, Miriam; Ascierto, Paolo A.
Afiliación
  • Vanella V; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Via Mariano Semmola snc, Naples, Italy.
  • Festino L; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Via Mariano Semmola snc, Naples, Italy.
  • Trojaniello C; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Via Mariano Semmola snc, Naples, Italy.
  • Vitale MG; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Via Mariano Semmola snc, Naples, Italy.
  • Sorrentino A; Department of Medicine (DAME), University Hospital of Udine, Udine, Italy.
  • Paone M; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Via Mariano Semmola snc, Naples, Italy.
  • Ascierto PA; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Via Mariano Semmola snc, Naples, Italy.
Curr Oncol Rep ; 21(9): 76, 2019 07 29.
Article en En | MEDLINE | ID: mdl-31359162
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas B-raf / Inhibidores de Proteínas Quinasas / Terapia Molecular Dirigida / Inmunoterapia / Melanoma / Antineoplásicos Tipo de estudio: Clinical_trials / Guideline Límite: Animals / Humans Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas B-raf / Inhibidores de Proteínas Quinasas / Terapia Molecular Dirigida / Inmunoterapia / Melanoma / Antineoplásicos Tipo de estudio: Clinical_trials / Guideline Límite: Animals / Humans Idioma: En Año: 2019 Tipo del documento: Article